Treatment Modalities in Pediatric Oncology

Treatment Modalities in Pediatric Oncology PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Treatment Modalities in Pediatric Oncology: Comprehensive Cancer Care for Children
Pediatric oncology involves a range of specialized treatments to address cancers affecting children and adolescents. The presentation “Treatment Modalities in Pediatric Oncology” explores the diverse therapies used to treat childhood cancers, focusing on innovative approaches and their impact on survival and quality of life.
The presentation highlights key treatment modalities such as chemotherapy, the primary treatment for cancers like leukemia, which uses drugs to target rapidly dividing cancer cells. Radiation therapy, including advanced methods like proton therapy, is often employed for brain tumors and sarcomas to minimize damage to surrounding tissues. Surgical oncology plays a vital role in removing tumors while preserving organ function, especially in solid tumors like Wilms tumor and neuroblastoma.
Innovative therapies like immunotherapy (CAR-T cells, monoclonal antibodies) and targeted therapy focus on precise, less toxic treatment approaches, while stem cell transplantation offers new hope for high-risk hematologic cancers. The presentation also emphasizes multimodal approaches, combining these therapies for enhanced outcomes.
This resource serves as an essential guide for understanding the state-of-the-art strategies transforming pediatric cancer care. By focusing on both efficacy and minimizing long-term effects, these treatments offer hope to children and their families worldwide.

Tags : Pediatric oncology, cancer treatment, chemotherapy, radiation therapy, immunotherapy, stem cell transplantation, targeted therapy, childhood cancer care

Published on : Dec 03, 2024 | Views : 55 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Treatment Modalities in Pediatric Oncology Exploring Therapies for Managing Childhood Cancers Dr. Vineeta Bose Oncologist & Hematologist
Slide 2-

Understanding Pediatric Oncology Treatment Pediatric oncology focuses on diagnosing and treating cancers in children and adolescents. Treatment approaches aim to cure cancer while minimizing long-term side effects. Multimodal therapy often involves a combination of treatments. Speaker Notes: Emphasize the importance of tailored approaches in pediatric oncology to ensure effective treatment with minimal impact on growth and development. Reference: Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014). Childhood and adolescent cancer statistics. CA: A Cancer Journal for Clinicians, 64(2), 83–103.
Slide 3-

Chemotherapy in Pediatric Oncology Primary treatment for many pediatric cancers, including leukemia and lymphoma. Mechanism: Uses drugs to kill rapidly dividing cancer cells. Often combined with other therapies. Common Drugs: Vincristine: Neuroblastoma, Wilms tumor. Doxorubicin: Bone and soft tissue sarcomas. Methotrexate: Leukemia. Side Effects: Hair loss, nausea, immunosuppression. Speaker Notes: Highlight the importance of personalized chemotherapy regimens to minimize toxicity while maximizing efficacy. Reference: Hunger, S. P., & Mullighan, C. G. (2015). Acute lymphoblastic leukemia in children. New England Journal of Medicine, 373(16), 1541–1552.
Slide 4-

Radiation Therapy in Pediatric Oncology Purpose: Kills cancer cells by using high-energy rays. Commonly used for brain tumors, Hodgkin’s lymphoma, and sarcomas. Types: External Beam Radiation (e.g., proton therapy). Internal Radiation (brachytherapy). Benefits of Proton Therapy: Reduced damage to healthy tissues. Fewer long-term side effects for growing children. Side Effects: Fatigue, skin irritation, potential developmental impact. Speaker Notes: Discuss how technological advancements like proton therapy reduce radiation exposure to nearby healthy tissues. Reference: Merchant, T. E., & Hua, C. H. (2010). Proton therapy for pediatric malignancies. Acta Oncologica, 49(6), 589–596.
Slide 5-

Surgery in Pediatric Oncology Goal: Remove tumors while preserving organ function. Role: Primary treatment for solid tumors like Wilms tumor and neuroblastoma. Diagnostic tool (biopsies). Advancements: Minimally invasive techniques. Organ-sparing surgeries (e.g., partial nephrectomy for Wilms tumor). Challenges: Tumor location, child’s age, and organ preservation. Speaker Notes: Highlight how surgical advancements have improved outcomes for children by reducing recovery time and preserving functionality. Reference: Ehrlich, P. F., & La Quaglia, M. P. (2011). Surgical treatment of pediatric solid tumors. Seminars in Pediatric Surgery, 20(4), 229–235.
Slide 6-

Immunotherapy in Pediatric Oncology Uses the immune system to fight cancer. Types of Immunotherapy: CAR-T Cell Therapy: Modified T cells target cancer cells (e.g., B-cell leukemia). Monoclonal Antibodies: E.g., Dinutuximab for neuroblastoma. Immune Checkpoint Inhibitors: Limited but growing use in pediatric cancers. Advantages: Targeted approach with fewer side effects. Effective in resistant cancers. Side Effects: Cytokine release syndrome, immune-related toxicity. Speaker Notes: Explain how immunotherapy is revolutionizing treatment for relapsed or refractory pediatric cancers like leukemia. Reference: Maude, S. L., Laetsch, T. W., Buechner, J., et al. (2018). Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New England Journal of Medicine, 378(5), 439–448.
Slide 7-

Targeted Therapy in Pediatric Oncology Precision medicine approach targeting cancer-specific molecules. Common Targets: ALK inhibitors: Neuroblastoma. BRAF inhibitors: Pediatric melanoma. Advantages: Minimal effect on normal cells. Highly effective in genetically-driven cancers. Limitations: Cost, limited availability for pediatric cancers. Speaker Notes: Emphasize how genetic testing identifies actionable mutations for targeted therapies. Reference: Pizzo, P. A., & Poplack, D. G. (Eds.). (2015). Principles and Practice of Pediatric Oncology. Philadelphia: Wolters Kluwer Health.
Slide 8-

Stem Cell Transplantation in Pediatric Cancer Used for hematologic cancers like leukemia and lymphoma. Types: Autologous: Patient’s own stem cells. Allogeneic: Donor stem cells. Role: Replace damaged bone marrow. Support aggressive chemotherapy. Risks: Graft-versus-host disease, infections. Speaker Notes: Discuss how advances in stem cell transplantation have improved survival rates in high-risk pediatric cancers. Reference: Jacobsohn, D. A., & Vogelsang, G. B. (2007). Acute graft-versus-host disease in children. Biology of Blood and Marrow Transplantation, 13(1), 24–32.
Slide 9-

Multimodal Therapy in Pediatric Oncology ombining surgery, chemotherapy, radiation, and immunotherapy. Benefits: Higher cure rates. Tailored to cancer type and stage. Example: Neuroblastoma treatment: Surgery + Chemotherapy + Dinutuximab (immunotherapy). Speaker Notes: Explain how multimodal therapy achieves synergy by combining complementary treatment strategies. Reference: Matthay, K. K., Villablanca, J. G., Seeger, R. C., et al. (2009). Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. New England Journal of Medicine, 341(2), 1165–1173.
Slide 10-

Challenges and Future Directions Challenges: Limited availability of targeted therapies for pediatric cancers. Long-term effects of treatment on growing children. Future Trends: Advanced precision medicine. Gene therapy for inherited cancer predispositions. Artificial intelligence for treatment planning. Speaker Notes: Highlight how ongoing research aims to improve outcomes while reducing long-term side effects. Reference: Barr, R., & Ferrari, A. (2016). Progress in pediatric oncology. The Lancet Oncology, 17(3), 250–251.
Slide 11-

Key Takeaways Pediatric oncology employs diverse treatment modalities, including chemotherapy, radiation, surgery, and emerging therapies like immunotherapy. Multimodal approaches offer the best outcomes. Research and innovation are paving the way for better survival rates and fewer long-term effects.
Slide 12-

Thank You